Masimo Co. (NASDAQ:MASI) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC reduced its stake in shares of Masimo Co. (NASDAQ:MASI) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,507 shares of the medical equipment provider’s stock after selling 1,416 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Masimo were worth $3,224,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MASI. American Century Companies Inc. grew its position in Masimo by 2.3% during the first quarter. American Century Companies Inc. now owns 8,799 shares of the medical equipment provider’s stock worth $1,281,000 after buying an additional 194 shares during the period. Great West Life Assurance Co. Can grew its position in shares of Masimo by 24.0% in the first quarter. Great West Life Assurance Co. Can now owns 59,540 shares of the medical equipment provider’s stock valued at $9,049,000 after purchasing an additional 11,543 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Masimo by 3.9% in the first quarter. Dimensional Fund Advisors LP now owns 226,526 shares of the medical equipment provider’s stock valued at $32,977,000 after purchasing an additional 8,501 shares during the last quarter. Canada Pension Plan Investment Board grew its position in shares of Masimo by 1,011.6% in the first quarter. Canada Pension Plan Investment Board now owns 2,390 shares of the medical equipment provider’s stock valued at $348,000 after purchasing an additional 2,175 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock valued at $695,050,000 after purchasing an additional 71,918 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MASI has been the topic of several research reports. Needham & Company LLC lowered shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Jefferies Financial Group reiterated a “hold” rating and issued a $121.00 price target (up from $107.00) on shares of Masimo in a research report on Tuesday, January 30th. StockNews.com upgraded shares of Masimo from a “sell” rating to a “hold” rating in a research report on Friday, March 29th. BTIG Research increased their price target on shares of Masimo from $145.00 to $166.00 and gave the company a “buy” rating in a research report on Monday, March 25th. Finally, Stifel Nicolaus upgraded shares of Masimo from a “hold” rating to a “buy” rating and raised their target price for the stock from $148.00 to $170.00 in a research report on Monday. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $137.43.

Masimo Stock Down 1.1 %

Shares of NASDAQ MASI opened at $136.62 on Thursday. Masimo Co. has a 1 year low of $75.22 and a 1 year high of $198.00. The firm’s 50 day moving average price is $135.65 and its 200 day moving average price is $113.89. The firm has a market cap of $7.23 billion, a P/E ratio of 90.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.22 and a current ratio of 2.18.

Masimo (NASDAQ:MASI) last announced its earnings results on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.43. The firm had revenue of $548.90 million for the quarter, compared to analyst estimates of $545.69 million. Masimo had a net margin of 3.98% and a return on equity of 13.77%. Masimo’s revenue was down 11.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.32 earnings per share. As a group, sell-side analysts anticipate that Masimo Co. will post 3.51 earnings per share for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.